Position in TEVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,671
+$2,129 QoQ
Shares Held
374
+6.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#578
of 671 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026IFG Advisory, LLC holds $298,076 across 12 Drug Manufacturers - Specialty & Generic names. TEVA ranks #5 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,979 | $142,210 | |
| 2 | HLN |
Haleon plc
|
5,494 | $51,259 | |
| 3 | VTRS |
Viatris Inc
|
2,122 | $33,697 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
56 | $30,342 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
374 | $12,671 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
64 | $10,786 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
250 | $9,050 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
300 | $7,611 |
All Filings in TEVA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,671 | 374 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $10,542 | 350 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||